MRBK Meridian Corp Insider Trading

Director Kenneth Thomas Warriner bought 1,000 shares of MRBK at $18.00, raising holdings to 3,050 shares (+48.8%)

Kenneth Thomas Warriner purchased 1,000 shares at $18.00 on 2026-05-11, increasing his holdings from 2,050 to 3,050 shares. The stock currently trades at $20.05, within its 52-week range of $11.16–$21.67 and 7.5% below the 52-week high. Over his cross-ticker open-market history, Warriner's prior buys averaged a 30-day return of -2.4%, suggesting a mixed timing record. At this specific ticker MRBK, he has one prior trade—a buy on 2026-04-30 that showed a 30-day return of -2.4%, with the 90-day outcome not yet measurable. Meridian Corp presents modest fundamentals with a P/E of 11.14 and annual revenue growth of +10.1%, alongside a market cap of $238.4M.

Director Imbesi buys 1,000 shares of MRBK at $17.38; stock down 19.7% from 52-week high amid -15.0% 30-day decline.

Director Anthony Mark Imbesi purchased 1,000 shares at $17.38 on 2026-05-13, bringing his holdings to 386,156 shares and signaling continued conviction in Meridian Corp despite recent weakness. The stock is trading 19.7% below its 52-week high of $21.67 and down 15.0% over the past 30 days, suggesting the director is buying into a pullback. Meridian's fundamentals remain solid with a P/E of 9.67, annual revenue growth of 10.1%, and a market cap of $207.0M, positioning this purchase within a reasonable valuation backdrop. The timing of this buy during a market-driven decline, combined with Imbesi's substantial post-transaction stake, warrants attention as a datapoint on insider confidence during volatility.

Director Kenneth Warriner buys 1,000 shares of Meridian Corp in open-market purchase.

Director Kenneth Warriner purchased 1,000 shares of Meridian Corp at market prices, establishing an initial position. The purchase occurred as the stock was trading modestly below its recent highs after a slight pullback, suggesting the director saw value at current levels despite recent weakness. Meridian itself is financially healthy—a profitable company with growing revenue and trading at a reasonable valuation multiple—making this purchase at a discounted price potentially more meaningful than a speculative bet. However, as a first-time purchase, this establishes only that a board member has begun building confidence in the stock; it lacks the pattern or conviction signal that repeated buying or substantial accumulation would provide. Without additional context on Warriner's track record as an investor or the board's broader sentiment, this represents a modest positive signal rather than a compelling vote of confidence.

Director Imbesi Anthony Mark bought 522 shares of MRBK at $15.72 on 2025-08-27; prior 5 buys at ticker all well-timed at 90-day mark with 100% win rate.

Imbesi's purchase of 522 shares extends a consistent buying pattern at Meridian—5 prior open-market buys over approximately 2 years, each followed by positive 90-day returns (range +7.8% to +34.6%). His cross-ticker track record shows 20 prior buys with an average 90-day return of +37.9% and a 100.00% win rate, suggesting strong pattern recognition in identifying entry points. The current transaction occurs as the stock sits -7.9% from its 52-week high but +5.8% over the past 30 days and +16.6% over 90 days, reflecting recent momentum. With a market cap of $177.9M, net income of $5.6M, annual revenue growth of +16.4%, and a P/E of 9.72, the company exhibits fundamental strength, though this discrete buy totaling $8,208.45 represents only +0.1% of his 385.2K post-transaction holdings.

Director Holland buys 608 shares at $14.30 across 3 transactions; prior trades at MRBK showed 5 of 5 well-timed buys (+1.3% to +26.3% at 90d).

Holland Robert T., a Director, executed 3 separate purchases totaling 608 shares for $8,695.33, increasing his holdings by 151.8% from 400 to 1,008 shares. His prior trading history at Meridian is notably consistent: 5 prior buys all delivered positive 90-day returns ranging from +1.3% to +26.3%, with a 100% win rate at this ticker on the 90-day measure. The current price of $13.44 sits 6% below the blended purchase price of $14.30, placing the stock -21.4% from its 52-week high but within the $9.87–$17.09 range. The company's fundamentals include $1.5M quarterly revenue, $2.4M net income, +16.4% annual revenue growth, and a 9.46 P/E, providing a lower-multiple backdrop. What distinguishes this filing is the sustained pattern: Holland's past five purchases at this ticker collectively demonstrated accurate timing, all generating gains by the 90-day horizon—a pattern an investor tracking this director's decisions at MRBK may view as material context alongside the current period's price weakness.

Director Casciato buys 2,000 shares at $13.79 avg; prior 5 MRBK buys all delivered 52%+ 90d returns.

Casciato, a director, purchased 2,000 shares across 3 separate transactions on 2025-05-09 at a blended average price of $13.79, increasing his holdings to 215,396 shares (215.4K shares). His prior MRBK trading pattern is notably consistent: all 5 prior buys at this ticker on 2023-05-09 achieved 90-day returns between +51.6% and +53.4%, establishing a perfect 5-of-5 well-timed pattern at this specific ticker. The current stock price of $14.12 is 8.0% above the purchase prices from today, though -17.4% from the 52-week high and down 16.6% over 90 days, suggesting a contrarian entry point relative to recent weakness. The company's fundamentals show profitability (net income $2.4M on revenue $1.5M in the latest quarter), 16.4% annual revenue growth, and a low P/E of 9.94, which provide context for the director's accumulation at a depressed price within a 52-week range.

MRBK CFO Lindsay Denise purchases 600 shares ($8,144.89) on 2025-05-08; 5-of-5 prior same-ticker buys showed 90-day gains (2.2%–31.4%)

Lindsay Denise, CFO of Meridian Corp, executed 3 separate open-market purchases totaling 600 shares for $8,144.89 (blended average $13.57) on 2025-05-08, growing her holdings from 88,000 to 88,600 shares (+0.7%). The stock is currently trading at $14.12, representing -17.4% from the 52-week high and +8.0% over the past 30 days. This acquisition is notable because her entire same-ticker trade history at MRBK consists of 5 prior buys, all of which proved well-timed at the 90-day mark, with post-purchase gains ranging from +2.2% to +31.4%. Her cross-ticker track record is equally robust: 20 prior open-market buys with an average 90-day return of +31.0% and a 90-day win rate of 100.00%. The company's fundamentals are solid, with net income ($2.4M) exceeding quarterly revenue ($1.5M), annual revenue growth of +16.4%, and a P/E of 9.94. This filing represents a continuation of an established pattern of well-timed accumulation by a senior financial officer.

Director Imbesi buys 1,000 shares at $10.74; cluster of 3 insiders buying in 14 days; cross-ticker track record shows 100% 90d win rate.

Director Anthony Mark Imbesi purchased 1,000 shares at $10.74 on 2024-08-19, increasing his holdings to 384.6K shares. This transaction occurs as part of a cluster pattern: 2 other insiders also bought within the past 14 days. Notably, Imbesi's cross-ticker track record across all open-market activity shows 20 prior buys with a 100% 90-day win rate and average 90-day return of +38.6%. At MRBK specifically, his prior 5 buy transactions were all well-timed at the 90-day mark, with 90-day returns ranging from +7.8% to +34.4%. The company's fundamentals show net income of $3.3M against quarterly revenue of $1.4M, a P/E of 11.42, and annual revenue growth of +4.1%. Stock price is currently $10.85 (down -22.1% from 52-week high of $13.93), creating context for the insider buying pattern.

Chairman Annas Christopher J. buys 2,000 shares of MRBK at $10.70; cluster pattern with 2 other insiders buying in 14 days

Annas Christopher J., Chairman & CEO, purchased 2,000 shares at $10.70 on 2024-08-19, increasing his holdings from 360,378 to 362,378 shares. His prior trades at MRBK show strong 90-day outcomes: 4 of 5 prior buys were well-timed, with 3 consecutive purchases in early May 2024 each delivering 90-day returns of +11.1%, +25.6%, and +29.6% respectively. A cluster pattern is present, with 2 other insiders also buying within the past 14 days. The company's fundamentals include a P/E of 11.42 and annual revenue growth of +4.1%; the stock is currently at $10.85, down 22.1% from its 52-week high of $13.93. This transaction signals sustained insider confidence at a depressed price level relative to recent history.

CFO Lindsay Denise bought 1,500 shares of MRBK at $10.68; 5 prior buys at this ticker all well-timed with positive 90d returns

Lindsay Denise, EVP and CFO, purchased 1,500 shares at $10.68 on 2024-08-09, expanding her holdings to 84,000 shares. The stock now trades at $10.21, down 26.7% from its 52-week high and down 11.2% over the past 30 days, placing this buy near recent lows within the $8.36–$13.93 range. Critically, Denise has executed 5 prior open-market buys at MRBK, and all 5 displayed positive 90-day returns, with outcomes ranging from +2.2% to +31.4%—a perfect timing pattern. Her cross-ticker track record spans 20 prior buys with a 100.00% 90-day win rate and average 90-day return of +31.9%, demonstrating a consistent ability to identify entry points that subsequently appreciate. The current valuation appears attractive on fundamentals: the stock trades at P/E 10.75 on $3.3M net income, and the company posted +4.1% annual revenue growth. This purchase represents a deliberate addition to her already substantial 84.0K-share position by an executive whose prior purchase timing has been consistently validated by subsequent price appreciation.